Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis

XA Phi, MJW Greuter, Inge-marie Obdeijn, JC Oosterwijk, TL Feenstra, N Houssami, GH de Bock

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{8654b64ccb8f43b6b198ce1393ff963a,

title = "Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis",

author = "XA Phi and MJW Greuter and Inge-marie Obdeijn and JC Oosterwijk and TL Feenstra and N Houssami and \{de Bock\}, GH",

year = "2019",

doi = "10.1016/j.breast.2019.03.004",

language = "Undefined/Unknown",

volume = "45",

pages = "82--88",

journal = "Breast",

issn = "0960-9776",

publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis

AU - Phi, XA

AU - Greuter, MJW

AU - Obdeijn, Inge-marie

AU - Oosterwijk, JC

AU - Feenstra, TL

AU - Houssami, N

AU - de Bock, GH

PY - 2019

Y1 - 2019

U2 - 10.1016/j.breast.2019.03.004

DO - 10.1016/j.breast.2019.03.004

M3 - Article

C2 - 30904701

SN - 0960-9776

VL - 45

SP - 82

EP - 88

JO - Breast

JF - Breast

ER -